9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Estimated reading time: < 1 min

Condition: Tumor

Estimated Enrollment: 35

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: to determine the maximum tolerated dose of PXD101 administered in combination with 5-FU,  to determine whether PXD101 alone can down-regulate thymidylate synthase in patient tumors,  ,

Interventions: belinostat, 5-Fluorouracil (5-FU)

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: March 2008

Completion Date: June 2008

Last  Posted Date: July 8, 2015

Location: Mayo Clinic Arizona, Scottsdale, Arizona, United States

Website Link: https://ClinicalTrials.gov/show/NCT00413322

Was this article helpful?
Dislike 0